UNH
UnitedHealth GroupPrevious close
406.97
Change
−3.94 / −0.96%
P/E (TTM) ?
23.0
Market Cap
$367B
1M
+10.87%
S&P 500 −0.91% over same period
Volume / Avg Volume
4.3M / 4.6M
0.94× average
Latest earnings analysisFY2026 Q2Reported 2026-07-16
UnitedHealth Group Q2 2026: profit up 61.0%, guidance raised
UnitedHealth beat on profit and raised full-year guidance, but the top line barely moved. Second-quarter revenue of $112.03 billion was up 0.4%, while net income of $5.48 billion rose 61.0% and adjusted EPS of $6.38 came in roughly 28.8% above the $4.9533 consensus estimate. Read this quarter as a margin story, not a growth story: pricing, medical cost management and a smaller membership base did the work.
Read the full analysis →Revenue$112.03BYoY +0.40%
EPS (non-GAAP)$6.38Beatest. $4.95
Next-day move+0.64%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-16 | $112B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-21 | $112B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-27 | $448B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-28 | $113B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-29 | $112B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-17 | $110B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 44 of its 5-year rangeMid-range
5-year range 12.7 – 38.6 · Median 23.8
Last 4 quarters: $1.6B in buybacks + $8.1B in dividends, 2.65% of market cap combined
P/E (TTM)
23.0
P/B
3.5
P/S
0.8
Dividend Yield
1.37%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.1% on average on the first trading day after, rising 4 times
Most recent +0.64%
Volatility & Correlation
1-year beta 0.32 · Correlation with S&P 500 0.12Low beta
Annualized volatility 35% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $0.66MNet selling $0.66M
- 08-21Conway Patrick HughChief Executive Officer, OptumSell$0.46M1,169 shares · Avg price 390.00
- 08-05Conway Patrick HughChief Executive Officer, OptumSell$0.21M500 shares · Avg price 410.00
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 112.03 | +0.4% | 88.1% | 5.48 | 6.04 |
| FY2026 Q1 | 111.72 | +2.0% | 88.5% | 6.28 | 6.90 |
| FY2025 Q4 | 113.22 | +12.3% | 88.8% | 0.01 | 0.05 |
| FY2025 Q3 | 113.16 | +12.2% | 88.9% | 2.35 | 2.59 |
| FY2025 Q2 | 111.62 | +12.9% | 88.3% | 3.41 | 3.74 |
| FY2025 Q1 | 109.58 | +9.8% | 88.7% | 6.29 | 6.85 |
| FY2024 Q4 | 100.81 | +6.8% | 87.6% | 5.54 | 5.99 |
| FY2024 Q3 | 100.82 | +9.2% | 88.3% | 6.06 | 6.51 |
| FY2024 Q2 | 98.86 | +6.4% | 88.5% | 4.22 | 4.54 |
| FY2024 Q1 | 99.80 | +8.6% | 88.9% | -1.41 | -1.53 |
| FY2023 Q4 | 94.43 | +14.1% | 89.2% | 5.46 | 5.85 |
| FY2023 Q3 | 92.36 | +14.2% | 89.8% | 5.84 | 6.24 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |
| ABT | 39.1 | +7.8% | 56.2% | +7.46% | Neutral |